Stem cell therapy and regenerative medicine now treat conditions once considered irreversible.
Spinal cord injury. Childhood autism. Multiple sclerosis. Cartilage degeneration. Treatment-resistant blood cancers.
The question is no longer whether stem cell therapy exists for your condition. It is which hospital, in which country, actually has the clinical depth to treat it?
This guide covers 12 verified hospitals across 7 countries, organised by condition so you can find what you need immediately.
My 1Health is a global medical tourism company partnered with all 12 hospitals featured here.
We have assisted 53,000+ patients from 95 countries, and we connect you to the right programme at no additional cost.
Hospital matching, cost estimates, visa support, coordination, and aftercare. We handle it all.
Find your condition below. Each row shows which hospitals and countries cover it.
| Your Condition | Hospitals and Countries Covered |
|---|---|
| Autism, cerebral palsy, spinal cord injury, ALS, stroke, Parkinson's, muscular dystrophy, traumatic brain injury | Neurogen (India), Vinmec (Vietnam), Kliniken Schmieder (Germany) |
| Leukaemia, lymphoma, myeloma, aplastic anaemia, MDS | The London Clinic (UK), Apollo (India), Bumrungrad (Thailand), Samsung (South Korea) |
| Thalassaemia, sickle cell disease | Apollo Hospital (India), Kokilaben (India) |
| Osteoarthritis, cartilage defects, AVN, tendon injuries, sports injuries | Fortis (India), Liv Hospital (Turkey), Kokilaben (India) |
| Relapsing-remitting MS, progressive MS, HSCT for MS | Anadolu (Turkey), Medipol (Turkey), Liv Hospital (Turkey) |
| GVHD, Crohn's disease, lupus, rheumatoid arthritis, severe asthma | Samsung (South Korea), Anadolu (Turkey) |
| Heart failure, cardiac conditions not eligible for bypass surgery | Apollo Hospitals (India) |
Best Hospitals for Stem Cell Therapy for Neurological Conditions
Conditions covered: autism, cerebral palsy, spinal cord injury, ALS, stroke, Parkinson's disease, muscular dystrophy, traumatic brain injury.
Most hospitals offering stem cell therapy for neurological conditions have built clinical programmes specifically around these conditions. They have the published evidence to back them up.
3 hospitals with the strongest published evidence for neurological stem cell therapy internationally are
- Neurogen Brain and Spine Institute in India
- Vinmec Healthcare System in Vietnam
- Kliniken Schmieder in Germany serves patients who require extended inpatient neurological rehabilitation.
1. Neurogen Brain and Spine Institute, Navi Mumbai, India
The entire hospital exists to treat neurological and neurodevelopmental conditions through regenerative medicine and intensive rehabilitation.
16,000+ patients treated. 9,500+ international patients from 70 countries. 100+ peer-reviewed publications.
How the treatment works
Neurogen uses a protocol called NRRT (Neuro-Regenerative Rehabilitation Therapy).
It combines 2 things:
- A procedure using stem cells taken from the patient's own bone marrow,
- Intensive rehabilitation programme covering physiotherapy, speech therapy, occupational therapy, and behavioural support.
The 2 are delivered together, not one after the other. The stem cell procedure prepares the nervous system for recovery. The rehabilitation is what activates it.
Published functional improvement rates:
| Condition | Improvement Rate |
|---|---|
| Autism | 91% functional improvement |
| Stroke (limb function) | 96% improvement |
| Spinal cord injury | 82% functional gains |
| Cerebral palsy (speech and motor) | 92% improvement |
| Muscular dystrophy (stabilisation) | 90% |
Programmes and costs (2026):
- 1-week programme: USD 8,000 to 13,000 (varies by room type)
- 2-week programme with integrative therapies: USD 10,500 to 17,500
- Both include: inpatient stay, nursing care, pre-treatment investigations, rehabilitation, meals for patient and one attendant, airport transfers
- Not included: medications after discharge, extended outpatient rehabilitation
Laboratory standards: ISO certified. Cell processing meets GLP and GMP standards (international benchmarks for laboratory quality and safety in cell therapy).
Our experience:
Families who choose the two-week programme report stronger functional gains at six-month follow-up.
The rehabilitation component is where Neurogen earns its outcomes data.
2. Vinmec Healthcare System, Hanoi, Vietnam
If you are a parent searching for published evidence that stem cell therapy works specifically for your child's neurological condition, Vinmec is the go-to solution.
It is the only hospital on this list with Phase 2 clinical trial data specifically for autism and governmental research certification specifically for cerebral palsy.
- Phase 2 study using bone marrow stem cells for autism in children: positive quality-of-life improvement confirmed post-treatment
- Government-certified cerebral palsy research: over 90% of patients showed improved motor function
- Director: Prof. Dr. Nguyen Thanh Liem, Nikkei Asia Prize recipient, recognised among the top 100 Asian scientists
- Research partnerships: Karolinska Institute (Sweden), Stanford University (USA), San Raffaele Hospital (Italy), Keele University (UK)
- Laboratory certified to ISO 15189:2012, meeting AABB and ISCT international quality standards for cell therapy
- Stem cell therapy at Vinmec is approved and regulated by Vietnam's Ministry of Health for cerebral palsy, spinal cord injury, and bone and joint disorders
- Cost: USD 8,000 to 18,000
Best for: Children under 12 with autism or cerebral palsy, where published clinical evidence is the deciding factor.
For adult neurological conditions, Neurogen's broader programme is the recommended starting point.
Comparing Neurogen and Vinmec for your child? We will advise on the better match.
3. Kliniken Schmieder, Allensbach and Heidelberg, Germany
Kliniken Schmieder is the right choice when the neurological condition requires weeks or months of structured inpatient rehabilitation inside a clinical environment.
- Best for: stroke recovery with significant motor and cognitive involvement, complex traumatic brain injury (TBI), MS with severe functional decline
- Regulatory standard: Cell-based therapies at Kliniken Schmieder operate under the European Medicines Agency (EMA) framework for Advanced Therapy Medicinal Products. This is the most rigorous regulatory standard for cell therapies in Europe.
- Cost: USD 25,000 to 60,000 depending on programme length
- Who travels here: GCC patients and high-income African patients who require European regulatory assurance and need long-term inpatient rehabilitation, not a short intervention programme
Think of it this way: Neurogen is the concentrated protocol. Kliniken Schmieder is the extended rehabilitation environment.
Best Hospitals for Stem Cell Therapy for Blood Cancers
Conditions covered: leukaemia (ALL, AML, CLL, CML), lymphoma, multiple myeloma, aplastic anaemia, myelodysplastic syndrome.
For blood cancers, the standard treatment is haematopoietic stem cell transplantation (HSCT), a procedure that replaces diseased bone marrow with healthy stem cells from either the patient or a matched donor.
The 4 hospitals below give you distinct options across cost, location, and regulatory standards. One of them is right for your condition.
1. The London Clinic
, London, United Kingdom
When regulatory assurance is non-negotiable, this is where you go.
The London Clinic holds JACIE accreditation. JACIE (Joint Accreditation Committee ISCT-Europe) is Europe's only official accreditation body for haematopoietic stem cell transplantation.
The unit is also Europe's largest accredited stem cell collection centre, processing 700+ donations per year.
- Established in 1985. 40 years of HSCT practice
- 12 beds in a purpose-built unit with positive pressure ventilation and HEPA filtration, specifically designed for patients with weakened immune systems
- Regulated by the Human Tissue Authority (HTA) and the Medicines and Healthcare Products Regulatory Agency (MHRA)
- Affiliated with Northwestern Medicine
- Works with Anthony Nolan, DKMS, and the British Bone Marrow Registry to find matched donors
- Named consultants: Prof. John Gribben, Dr. Michael Potter, Dr. Richard Kaczmarski, Dr. Riaz Jan-Mohamed
- Transplant types available: allogeneic (donor), autologous (own cells), syngeneic (identical twin)
- Cost: USD 80,000 to 150,000
Best for: International patients where European regulatory oversight is the priority.
→ Considering The London Clinic? Get a cost estimate and eligibility check.
2. Apollo Hospital, Delhi, India
Apollo Delhi offers the broadest haematology coverage on this list. BMT for blood cancers, thalassaemia, sickle cell disease, and stem cell therapy for heart failure patients who are not candidates for coronary bypass surgery.
If you are travelling from Nigeria, Kenya, Ghana, Bangladesh, or the GCC, this is the most well-established corridor in India for international patients.
- JCI-accredited across multiple campuses
- Both allogeneic (donor) and autologous (own cells) transplant programmes are available, including haploidentical transplants for patients without a fully matched donor
- Named specialist: Dr. P.K. Jayachandran, Consultant in Medical Oncology and Haematology, Apollo Cancer Centre, Chennai
- Dedicated coordination infrastructure for patients from Nigeria, Kenya, Ghana, Bangladesh, and the GCC
- Cost (BMT): USD 18,000 to 35,000
For patients with complex cancers requiring proton therapy, Apollo Proton Cancer Centre in Chennai is part of the same network
Coordinating a blood cancer BMT from Africa or South Asia? Our Apollo team responds within 24 hours.
3. Bumrungrad International Hospital, Bangkok, Thailand
For patients who prefer Bangkok, or anyone travelling from the Middle East who routes through Southeast Asia, Bumrungrad is one of the most credentialled bone marrow transplant hospitals in the region.
- First hospital in Asia to receive JCI accreditation (2002), re-accredited 5 times
- Ranked Thailand's No.1 hospital for five consecutive years by Newsweek. Best Specialised Hospital in APAC for Oncology in 2023 and 2024. Global top 100 in 2024
- 1.1 million patients annually, including 520,000+ international patients from 190 countries
- 24-hour BMT Centre with dedicated stem cell laboratories, HEPA-filtered inpatient units, and AI-assisted diagnostics
- Donor options: HLA-matched sibling, unrelated matched donor, and haploidentical (partially matched family member)
- Autologous BMT from USD 40,000. Allogeneic (related donor) transplant from USD 95,000
- 70+ interpreter services, including Arabic, Swahili, and French
Best for: International patients travelling through Bangkok, patients requiring paediatric BMT in Southeast Asia.
4. Samsung Medical Centre, Seoul, South Korea
Samsung's Cell and Gene Therapy Institute is South Korea's leading hospital for stem cell treatment in haematological cancers.
If you have already attempted a bone marrow transplant and it has not worked, Samsung is where you look next.
- Dedicated stem cell manufacturing unit producing cell products under pharmaceutical-grade laboratory standards
- Active clinical research into stem cell-based treatment for immune diseases and musculoskeletal conditions
- National registry for patients with rare genetic disorders
- Ranked among Newsweek's World's Best Hospitals 2026
- Cost: USD 25,000 to 55,000
Best for:
Treatment-resistant blood cancers where standard bone marrow transplant has not achieved remission, and patients who need access to the most current cell therapy protocols in East Asia.
Best Hospitals for Stem Cell Therapy for Thalassaemia and Sickle Cell Disease
Conditions covered: beta-thalassaemia major, thalassaemia intermedia, sickle cell anaemia, sickle cell crisis, haemoglobin SC disease.
If your child has thalassaemia or sickle cell disease, you already know this is not the same as a blood cancer.
You are probably a parent who has been managing this condition for years, who knows the clinical landscape better than many doctors you have seen, and who is now ready to pursue a transplant.
India is where most of these families end up, and for very good reason.
India treats more thalassaemia and sickle cell cases from African and South Asian international patients than any other destination globally.
That patient volume has driven the development of a specific donor matching infrastructure that Western centres simply have not built.
1. Apollo Hospital, Delhi, India
Apollo's thalassaemia and sickle cell programme stands out.
- Haploidentical transplant programme for patients without a matched sibling donor
- Efficient pre-arrival coordination: visa documentation, accommodation, cost estimates
- Cost: USD 18,000 to 35,000
2. Kokilaben Dhirubhai Ambani Hospital, Mumbai, India
The paediatric BMT unit is led by Dr. Santanu Sen (MBBS, DCH, FRCPCH, FRCP London and Edinburgh, CCT UK), trained in the UK.
- Dedicated paediatric BMT unit with HEPA filtration
- Conditions: thalassaemia major, sickle cell disease, aplastic anaemia, inherited immune deficiency syndromes, metabolic diseases
- Transplant options: allogeneic bone marrow, peripheral stem cell, umbilical cord blood
- Cost: USD 18,000 to 32,000
For children under 10 travelling from West Africa, Kokilaben is our first recommendation for this patient profile.
Best Hospitals for Stem Cell Therapy for Orthopaedic Conditions
Conditions covered: knee osteoarthritis, hip osteoarthritis, cartilage defects, avascular necrosis (AVN), rotator cuff tears, Achilles tendon injury, non-union fractures, sports injuries.
Orthopaedic regenerative medicine is nothing like transplant therapy. No donor matching. No immune suppression.
If you are being told that joint replacement surgery is your only remaining option, it is worth knowing that for a growing number of patients, it is not.
1. Fortis Hospitals, India (Lead Centre: Mohali)
The orthopaedic regenerative medicine programme was pioneered by Dr. Mandeep Singh Dhillon at Fortis Mohali. The protocol now extends across the broader Fortis network in India.
Dr. Dhillon's credentials:
- Founder President of the Indian Ortho Biologics Society (IBOS).
- Former President of the Indian Orthopaedic Association (2018).
- Chairman of Research for AO Trauma Asia Pacific.
- His landmark PRP study has nearly 1,000 citations.
Treatment:
Allogeneic MSC therapy uses donor-derived mesenchymal stem cells.
Immediately available.
No harvesting surgery.
No waiting for cell preparation.
Clinical outcomes:
| Measure | Result |
|---|---|
| VAS pain score reduction at 12 months | 13 to 27 points |
| Cartilage volume increase (Phase 2 trials) | 70% of patients |
| Non-union fracture union rate | 80 to 90% |
| Adverse events | Mild and transient in fewer than 10% of patients |
- Conditions: knee, hip, and shoulder osteoarthritis, cartilage defects, AVN, rotator cuff and Achilles tendon injuries, non-union fractures
- Cost: significantly lower than joint replacement surgery.
2. Liv Hospital, Istanbul, Turkey
LivMedCell is Turkey's first hospital-based GMP-certified cell production centre (established 2014).
Liv manufactures personalised cell products under pharmaceutical-grade standards.
- Prof. Dr. Erdal Karaöz, founder, 200+ published articles, Harvard Medical School experience
- 36-person multidisciplinary clinical and research team
- Licensed cell products: MSC from umbilical cord, fat tissue, cartilage, synovial tissue, exosomes, SVF, bone marrow mononuclear cells
- Orthopaedic applications: joint degeneration, sports injuries, avascular necrosis, tendon conditions
- Additional applications: neurological, cardiology, autoimmune
- Cost: USD 8,000 to 25,000, depending on condition and protocol
For patients travelling to Turkey for orthopaedic regenerative medicine, Liv is the recommendation when personalised GMP-manufactured cell products are the clinical requirement.
3. Kokilaben Dhirubhai Ambani Hospital, Mumbai, India (Orthopaedic Reference)
Kokilaben's orthopaedic regenerative programme is led by Dr. Dinshaw Pardiwala and covers articular cartilage repair, autologous osteoblasts and stem cells for AVN, and PRP for musculotendinous conditions.
Best for patients already travelling to Kokilaben for a BMT procedure who want orthopaedic treatment at the same institution on the same trip.
Best Hospitals for Stem Cell Therapy for Multiple Sclerosis
The evidence is the strongest it has ever been.
Multiple prospective trials, including the MIST trial, have shown that haematopoietic stem cell transplantation outperforms disease-modifying therapies in relapsing-remitting Multiple Sclerosis.
These are hospitals that treat MS-HSCT specifically, not neurological conditions generally.
1. Anadolu Medical Center, Gebze, Turkey
Johns Hopkins Medicine International is affiliated.
- BMT Centre was established in 2010. Over 3,000 transplants performed
- Dr. Zafer Gulbas, 40+ years oncohaematology experience, team of 60+ specialists
- 22 simultaneous transplant capacity. 81% success rate for autologous procedures
- Treats: relapsing-remitting MS, progressive MS, Crohn's disease, treatment-resistant autoimmune conditions
- JCI accredited. Cost: USD 25,000 to 50,000
The strongest Multiple Sclerosis- Haematopoietic Stem Cell transplant inquiries volume we see comes from UK patients who cannot access the treatment on the NHS and GCC patients seeking a credible alternative to European private hospital pricing.
→ Researching HSCT for MS? Share your MS type and treatment history, and we will advise on fit.
2. Medipol Mega University Hospital, Istanbul, Turkey
Medipol collaborates with the Regenerative and Restorative Medicine Research Centre. BMT protocols here are shaped by ongoing research.
- Published success rates: 91.5% BMT, 92% stem cell procedures
- Paediatric transplant specialists: Sema Anak and Ebru Sarybeyoglu
- 25,000 international patients annually. Language support: 15 languages, including Arabic and Russian
- Cost: USD 30,000 to 65,000
Anadolu has the Johns Hopkins affiliation. Medipol has the highest published success rate in Turkey. For MS patients deciding between the two, that is the distinction that matters.
3. Liv Hospital, Istanbul, Turkey (MSC Protocols for MS)
For MS patients whose neurologist has advised against the intensity of HSCT conditioning, Liv Hospital's LivMedCell GMP laboratory offers MSC-based protocols focused on neuroregenerative modulation and inflammation reduction.
Liv is transparent that the evidence base for MSC therapy in MS is less established than for HSCT. This is the option when HSCT is not clinically appropriate.
Best Hospitals for Stem Cell Therapy for Autoimmune Conditions
Conditions covered: GVHD, Crohn's disease, lupus (SLE), rheumatoid arthritis, severe treatment-resistant asthma.
Autoimmune stem cell therapy works differently from cancer treatment. The goal is to reset or recalibrate an immune system that is attacking the body's own tissues.
For patients who have failed conventional immunosuppression, this matters.
1. Samsung Medical Centre, Seoul, South Korea
Samsung is South Korea's leading hospital for advanced cell therapy in autoimmune conditions.
Its dedicated Cell and Gene Therapy Institute manufactures stem cell products under pharmaceutical-grade laboratory standards and runs active clinical research into cell-based treatments for immune diseases.
Best for: GVHD (graft-versus-host disease, a complication that can follow a previous transplant), Crohn's disease, lupus, rheumatoid arthritis, and severe asthma.
Specifically for patients where standard immunosuppressing medications have stopped working.
Cost: USD 25,000 to 55,000.
2. Anadolu Medical Center, Gebze, Turkey
Anadolu's autoimmune programme goes beyond MS. For Crohn's disease specifically, HSCT has shown durable remission in patients who have failed conventional biologics. For patients where HSCT is the goal rather than GMP cell manufacturing technology, Anadolu offers a significant cost advantage over Samsung.
The Johns Hopkins affiliation and JCI accreditation give Anadolu the institutional credibility this patient group demands. Cost: USD 25,000 to 50,000.
Best Hospital for Stem Cell Therapy for Cardiac Conditions
Apollo Hospital, Delhi, India
Apollo Delhi offers cardiac stem cell therapy via Transmyocardial Revascularisation (TMR), a procedure that uses a combination of laser treatment and autologous stem cells from the patient's own bone marrow to improve blood flow to the heart.
It is specifically for heart failure patients who are not candidates for conventional coronary bypass surgery.
This is not the same as a bone marrow transplant for blood cancers. It is a separate programme within Apollo's cardiac department, coordinated through the same My 1Health.
Best for: Heart failure patients who have been told they are not suitable for bypass surgery and are looking for an alternative treatment option.
Cost: Available on request. Contact My 1Health for a condition-specific estimate.
All 12 Hospitals at a Glance
Every hospital is a verified My 1Health partner. You pay the same rate as going directly to the hospital. No facilitation fee.
| Hospital | Country | Specialty Focus | Cost USD 2026 | Accreditation |
|---|---|---|---|---|
| Neurogen Brain and Spine Institute | India | Neurology, autism, CP, SCI, ALS | 8,000 to 17,500 | ISO, GMP, GLP |
| Vinmec Healthcare System | Vietnam | Autism, CP, neurological | 8,000 to 18,000 | ISO 15189, AABB, ISCT |
| Apollo Hospital Delhi | India | BMT, thalassaemia, sickle cell, cardiac | 18,000 to 35,000 | JCI |
| Kokilaben Dhirubhai Ambani Hospital | India | Paediatric BMT, thalassaemia, orthopaedics | 18,000 to 32,000 | JCI |
| Fortis Hospitals | India | Orthopaedics, cartilage, AVN | Contact for estimate | JCI |
| Liv Hospital | Turkey | Orthopaedics, neurology, autoimmune | 8,000 to 25,000 | JCI, GMP |
| Anadolu Medical Center | Turkey | MS-HSCT, autoimmune, BMT | 25,000 to 50,000 | JCI, Johns Hopkins |
| Medipol Mega University Hospital | Turkey | BMT, MS, academic research protocols | 30,000 to 65,000 | JCI academic, ISO |
| Bumrungrad International Hospital | Thailand | BMT, thalassaemia, blood cancers | 40,000 to 170,000 | JCI (5 times re-accredited) |
| Samsung Medical Centre | South Korea | Blood cancers, autoimmune, cell therapy | 25,000 to 55,000 | JCI |
| Kliniken Schmieder | Germany | Neurological rehabilitation, ATMPs | 25,000 to 60,000 | EMA regulated |
| The London Clinic | UK | Blood cancers, HSCT | 80,000 to 150,000 | JACIE, HTA, MHRA |
What Stem Cell Therapy Costs by Condition in 2026 (USD)
All costs in USD. Benchmarks, not quotes. Final costs depend on transplant type, donor matching, and length of stay.
| Condition | India | Turkey | Thailand | S. Korea | Germany | Vietnam | UK |
|---|---|---|---|---|---|---|---|
| Neurological (autism, CP, SCI) | 8,000-17,500 | 8,000 to 20,000 | N/A | N/A | 25,000 to 60,000 | 8,000 to 18,000 | N/A |
| Blood cancers (BMT) | 18,000 to 35,000 | 25,000 to 65,000 | 40,000 to 170,000 | 25,000 to 55,000 | N/A | N/A | 80,000 to 150,000 |
| Thalassaemia / sickle cell | 18,000 to 32,000 | 25,000 to 45,000 | 40,000 to 95,000 | N/A | N/A | N/A | N/A |
| Orthopaedic (cartilage, AVN) | Contact Fortis | 8,000 to 25,000 | N/A | N/A | N/A | N/A | N/A |
| MS-HSCT | N/A | 25,000 to 65,000 | N/A | N/A | N/A | N/A | N/A |
| Autoimmune (GVHD, Crohn's) | N/A | 25,000 to 50,000 | N/A | 25,000 to 55,000 | N/A | N/A | N/A |
Three Things That Change Your Final Cost
1. Transplant type. Autologous (your own cells) costs less than allogeneic (donor cells). No donor matching, less conditioning, shorter stay.
2. Donor matching complexity. Finding an unrelated matched donor adds registry search costs and time. Haploidentical transplants from partially matched family members reduce the search but increase clinical management. Mismatched transplants need more intensive GVHD management, which extends stays.
3. Length of stay. Most quotes cover the procedure and standard inpatient period only. Blood cancer BMT: 30 to 60 days. Neurogen neurological programmes: 1 to 2 weeks. MS-HSCT: 4 to 8 weeks minimum. Accommodation and companion costs add USD 3,000 to 15,000 to the total.
→ Get a full cost breakdown, including accommodation and follow-up estimates for your condition.
How My 1Health Supports Your Stem Cell Therapy Abroad
Travelling abroad for stem cell therapy involves more than booking a hospital. Here is exactly how we coordinate your journey from first question to last follow-up, at no additional cost.
| Step | What We Do |
|---|---|
| 1. Free initial consultation | Review your diagnosis. Identify the right hospital and programme. Give you an honest assessment of what stem cell therapy can and cannot do for your condition. |
| 2. Hospital matching | Connect you with the verified hospital that best fits your condition, budget, and travel corridor based on 53,000+ coordinated cases. |
| 3. Cost estimate | Clear breakdown covering procedure, inpatient stay, inclusions, exclusions, and realistic total trip cost. |
| 4. Visa and documentation support | Prepare the medical letters and documentation required for your treatment visa application. |
| 5. Travel planning | Structure your travel timeline around admission and discharge dates so your trip is planned around your medical needs, not convenience. |
| 6. On-ground coordination | Airport transfer, admission support, communication between your family and the clinical team, companion accommodation guidance. |
| 7. Post-treatment follow-up | Discharge summaries, follow-up consultation scheduling, continued rehabilitation coordination if required. |
Every service is free. You pay the same rate as going directly to the hospital. My 1Health's same-price guarantee means no markup, no hidden fees, and no financial incentive for us to recommend one hospital over another.
